ad26.cs.01
Vaccineexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2011 (NCT01397227)
Timeline
2010s
- Jan 1, 2011
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Plasmodium falciparum D6Immunity, active
Plasmodium falciparum D6 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ad26.cs.01
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01397227 | Phase 1/Phase 2 (Phase 2) | Jun 1, 2011 | Crucell, PATH, University of Washington |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Crucell | For profit | 1 | 1 | 1 | 2011 |
| PATH | Academic/Hospital | 1 | 0 | 1 | 2011 |
| University of Washington | Academic/Hospital | 1 | 0 | 1 | 2011 |
3 organizations
Page 1 / 1